ZSA-215 is an orally active STING agonist with an EC50 value of 3.3 µM. In the MC38 colon cancer model, ZSA-215 facilitates tumor regression and supports long-term survival in mice. It is utilized for colon cancer research.
Target:
STING
* VAT and and shipping costs not included. Errors and price changes excepted
